Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00734149 · ClinicalTrials.gov registry record · Phase 2

Bortezomib With Melphalan and Prednisone for Multiple Myeloma

A Phase 2 study of Multiple Myeloma, sponsored by Duke University.

Completed
Registry status
Phase 2
Development phase
45
Enrollment target
1
Study location

NCT00734149 is a Phase 2 study of Multiple Myeloma that has completed, run by Duke University. The registered enrollment target is 45 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00734149, a Phase 2 study of Multiple Myeloma, has completed, sponsored by Duke University.

COMPLETED
Registry status
Phase 2
Development phase
45 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the efficacy of bortezomib in combination with melphalan and prednisone to achieve complete responses for patients with previously untreated multiple myeloma compared to an historical control group. This trial will also evaluate the safety and toxicity of this regimen as well as evaluate the duration of response of this regimen.

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG Melphalan
  • DRUG Prednisone
  • DRUG Bortezomib

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2004-07
Est. Completion 2008-02
Phase Phase 2

Sponsor

Duke University

1,725 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00734149

The ClinicalTrials.gov registry entry for NCT00734149 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (92% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 3 interventions - of which Melphalan is the first listed.

NCT00734149 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00734149 about?

NCT00734149 is a clinical study titled "Bortezomib With Melphalan and Prednisone for Multiple Myeloma". The purpose of this study is to assess the efficacy of bortezomib in combination with melphalan and prednisone to achieve complete responses for patients with previously untreated multiple myeloma compared to an historical control group. This trial will also evaluate the safety and toxicity of this ...

What is the current status of trial NCT00734149?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2004-07. Estimated completion is 2008-02.

What conditions does trial NCT00734149 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT00734149?

The interventions under investigation include: Melphalan (DRUG), Prednisone (DRUG), Bortezomib (DRUG).

Who is sponsoring clinical trial NCT00734149?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00734149 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.